Skip to main content

KINGDON CAPITAL MANAGEMENT, L.L.C.

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1000097 NEW YORK, NY

Position in SNDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$54,650,000
-$3,750,000 QoQ
Shares Held
2,500,000
0.0% QoQ
Ownership
2.80%
of shares outstanding
% of Portfolio
7.47%
of 13F equity value
Holder Rank
#11
of 240 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

KINGDON CAPITAL MANAGEMENT, L.L.C. holds $112,338,858 across 9 Biotechnology names. SNDX ranks #1 (48.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SNDX
Syndax Pharmaceuticals Inc
This page
2,500,000 $54,650,000

All Filings in SNDX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,650,000 2,500,000
2026-03-31 $58,400,000 2,500,000
2025-12-31 $49,373,500 2,350,000
2025-09-30 $38,462,500 2,500,000
2025-06-30 $19,666,500 2,100,000
2025-03-31 $24,570,000 2,000,000
2024-12-31 $26,440,000 2,000,000
2024-09-30 $19,250,000 1,000,000
2024-06-30 $18,374,206 894,993
2024-03-31 $21,300,833 894,993
2023-12-31 $16,127,391 746,293